
Belgium, Germany, the Netherlands and France received the first parties of doses of the American Moderna vaccine against coronavirus infection, according to Monday The Brussels Times and other Belgian media. There is no information about the size of the parties received parties and their storage places.
The European agency of medicines last Wednesday was recommended by the use of this vaccine to combat Covid-19 in the European Union. "The European Medicon Agency (EMA) recommended allowing the production of Moderna vaccines to the prevention of coronavirus infection Covid -19 in people aged 18 years of age," the agency said.
On the same day, the European Commission (EC) approved the commercial use of Moderna vaccine in the European Union.
"With the Moderna vaccine, now the second allowed in the EU, we will have 160 million additional doses. And other vaccines will arrive. Europe provided up to two billion doses of potential vaccines against Covid -19. We have more than enough safe and effective vaccines to protect all Europeans," said the chairman of the European -report of Ursula von Lyain.
Prior to this, the EC has already given permission to the BionTech/Pfizer vaccine, the contract for which provided for the purchase of 300 million doses. However, last Friday Ursula von der Lyain announced that the European Commission offered the EU member states to purchase an additional 200 million doses of Biontech and Pfizer vaccines with the possibility of acquiring another 100 million, Interfax reports.
“We already have 300 million doses of Biontech/Pfizer vaccine. And the good news is that we agreed with this enterprise to change the contract towards the increase, and with this new contract we will be able to receive another 300 million additional doses of Biontech/Pfizer vaccine,” the head of the European Commission for a press conference in Brussels.